久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/01 | 5,520 | 5,680 | 5,480 | 5,670 | +120 | +2.2% | 172,500 |
2019/01/31 | 5,590 | 5,610 | 5,470 | 5,550 | +20 | +0.4% | 251,000 |
2019/01/30 | 5,560 | 5,600 | 5,490 | 5,530 | -10 | -0.2% | 221,100 |
2019/01/29 | 5,440 | 5,540 | 5,410 | 5,540 | +80 | +1.5% | 149,900 |
2019/01/28 | 5,480 | 5,540 | 5,430 | 5,460 | -20 | -0.4% | 139,500 |
2019/01/25 | 5,400 | 5,550 | 5,380 | 5,480 | +20 | +0.4% | 162,700 |
2019/01/24 | 5,490 | 5,510 | 5,400 | 5,460 | +40 | +0.7% | 166,600 |
2019/01/23 | 5,490 | 5,500 | 5,400 | 5,420 | -130 | -2.3% | 149,800 |
2019/01/22 | 5,650 | 5,670 | 5,530 | 5,550 | -20 | -0.4% | 134,700 |
2019/01/21 | 5,630 | 5,700 | 5,560 | 5,570 | -40 | -0.7% | 137,400 |
2019/01/18 | 5,540 | 5,680 | 5,510 | 5,610 | +80 | +1.4% | 147,000 |
2019/01/17 | 5,470 | 5,530 | 5,390 | 5,530 | +40 | +0.7% | 166,900 |
2019/01/16 | 5,330 | 5,530 | 5,310 | 5,490 | +200 | +3.8% | 333,800 |
2019/01/15 | 5,270 | 5,530 | 5,200 | 5,290 | -560 | -9.6% | 483,400 |
2019/01/11 | 5,980 | 6,090 | 5,780 | 5,850 | -130 | -2.2% | 237,200 |
2019/01/10 | 6,130 | 6,140 | 5,960 | 5,980 | -160 | -2.6% | 165,800 |
2019/01/09 | 6,040 | 6,210 | 6,020 | 6,140 | +190 | +3.2% | 225,200 |
2019/01/08 | 5,990 | 6,040 | 5,880 | 5,950 | -80 | -1.3% | 255,800 |
2019/01/07 | 5,970 | 6,080 | 5,920 | 6,030 | +180 | +3.1% | 175,900 |
2019/01/04 | 5,820 | 5,950 | 5,820 | 5,850 | -220 | -3.6% | 235,700 |
2018/12/28 | 6,210 | 6,210 | 6,020 | 6,070 | -150 | -2.4% | 261,000 |
2018/12/27 | 5,980 | 6,280 | 5,900 | 6,220 | +430 | +7.4% | 281,900 |
2018/12/26 | 5,740 | 5,860 | 5,690 | 5,790 | +90 | +1.6% | 254,500 |
2018/12/25 | 5,860 | 5,900 | 5,670 | 5,700 | -550 | -8.8% | 194,500 |
2018/12/21 | 6,440 | 6,440 | 6,230 | 6,250 | -210 | -3.3% | 270,500 |
2018/12/20 | 6,500 | 6,660 | 6,420 | 6,460 | -110 | -1.7% | 230,600 |
2018/12/19 | 6,480 | 6,640 | 6,430 | 6,570 | -90 | -1.4% | 276,700 |
2018/12/18 | 6,880 | 6,940 | 6,650 | 6,660 | -320 | -4.6% | 225,700 |
2018/12/17 | 6,930 | 6,980 | 6,720 | 6,980 | -20 | -0.3% | 279,900 |
2018/12/14 | 6,980 | 7,110 | 6,950 | 7,000 | -100 | -1.4% | 315,600 |
2018/12/13 | 7,170 | 7,200 | 7,010 | 7,100 | -10 | -0.1% | 158,700 |
2018/12/12 | 6,980 | 7,160 | 6,980 | 7,110 | +230 | +3.3% | 175,600 |
2018/12/11 | 7,100 | 7,130 | 6,870 | 6,880 | -220 | -3.1% | 136,800 |
2018/12/10 | 7,000 | 7,140 | 6,970 | 7,100 | -30 | -0.4% | 156,400 |
2018/12/07 | 6,870 | 7,170 | 6,870 | 7,130 | +290 | +4.2% | 240,800 |
2018/12/06 | 7,200 | 7,220 | 6,800 | 6,840 | -460 | -6.3% | 187,500 |
2018/12/05 | 7,110 | 7,310 | 7,060 | 7,300 | +60 | +0.8% | 161,900 |
2018/12/04 | 7,250 | 7,360 | 7,230 | 7,240 | -70 | -1% | 157,900 |
2018/12/03 | 7,350 | 7,400 | 7,270 | 7,310 | +60 | +0.8% | 182,100 |
2018/11/30 | 7,220 | 7,280 | 7,030 | 7,250 | -20 | -0.3% | 456,300 |
2018/11/29 | 7,200 | 7,320 | 7,170 | 7,270 | +280 | +4% | 333,800 |
2018/11/28 | 7,060 | 7,090 | 6,990 | 6,990 | ±0 | ±0% | 240,000 |
2018/11/27 | 6,960 | 7,020 | 6,910 | 6,990 | +10 | +0.1% | 182,500 |
2018/11/26 | 7,100 | 7,110 | 6,970 | 6,980 | -140 | -2% | 152,000 |
2018/11/22 | 7,000 | 7,140 | 7,000 | 7,120 | +160 | +2.3% | 148,000 |
2018/11/21 | 6,880 | 6,990 | 6,880 | 6,960 | -70 | -1% | 178,100 |
2018/11/20 | 7,060 | 7,140 | 6,980 | 7,030 | -110 | -1.5% | 155,900 |
2018/11/19 | 7,050 | 7,180 | 7,050 | 7,140 | +90 | +1.3% | 157,000 |
2018/11/16 | 6,880 | 7,110 | 6,830 | 7,050 | +160 | +2.3% | 250,500 |
2018/11/15 | 6,800 | 6,950 | 6,780 | 6,890 | +20 | +0.3% | 134,300 |
1601~
1650
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 429,900円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.11倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 144,000円 | -11.0% | +206.6% | 0.00% | 14.30倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ツムラ | 364,900円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 322,600円 | +3.6% | -15.3% | 3.84% | 9.06倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム